Fabry disease (FD) Program in Pharmaceutical Benefits Scheme (PBS) 012-24080524
This document outlines details of PBS-subsidised migalastat for patients with Fabry disease (FD).
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.
Fabry disease (FD) quick reference
|
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type |
Prescriber self-serve |
|
Initial PB373 form |
Written Electronic S85: migalastat |
No |
OPA |
Must be treated by a:
|
Yes - delayed assessment due to DPMQ (cost) |
|
Grandfather PB374 form |
Written Electronic S85: migalastat |
No |
OPA |
Must be treated by a:
|
Yes - delayed assessment due to DPMQ (cost) |
|
Continuing |
Telephone Electronic S85: migalastat |
No |
OPA |
Must be treated by a:
|
Yes |